Abstract:The definitive diagnosis of Alzheimer's disease(AD) are hampered by the lack of effective biomarkers of the underlying pathology.The positron emission tomographic(PET) is one of the most potential biomarker of clinical diagnosis of Alzheimer disease.The progress of florbetapir F18(18F-AV-45)PET imaging to identify b-amyloid pathology in the brains of individuals during life were introduced.
What problem does this paper attempt to address?